Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
S-layer protein A (SlpA) is the primary structural component of the complex surface layer that coats *Clostridioides difficile*, forming an unusually intricate paracrystalline array composed of high- and low-molecular-weight fragments derived from proteolytic cleavage of the SlpA precursor. This surface-exposed protein functions as a multifunctional adhesin and virulence factor, mediating host cell attachment, biofilm formation, immune modulation, and protection from environmental stresses and host defenses. SlpA also serves as the primary receptor for *C. difficile* bacteriophages, making it critical for phage susceptibility. The protein exhibits significant sequence variability between strains, with 13 identified S-layer cassette types that facilitate immune system evasion while maintaining essential structural functions. Although SlpA deletion does not render *C. difficile* non-pathogenic, it substantially reduces virulence through decreased toxin production and impaired host cell adhesion, while paradoxically increasing biofilm formation. The rapid in vivo selection for S-layer-restored variants following infection demonstrates SlpA's essential contribution to disease severity and represents both a promising therapeutic target and a potential challenge due to strong selective pressure favoring its restoration.
Potential therapeutic mechanisms targeting SlpA include: Inhibiting SlpA-mediated host cell adhesion; Blocking bacteriophage receptor function to enhance phage therapy; Disrupting S-layer assembly and stability; Enhancing bacterial susceptibility to antimicrobial peptides and bacteriolytic enzymes.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on S-layer protein A (SlpA) (SlpA).